In the present study, we set out to clarify the effect of aberrant expression of SIPA1 on glucose metabolism in breast cancer cells and demonstrated that SIPA1 enhanced aerobic glycolytic flux and up-regulated the expression of glycolysis-related genes in breast cancer cells through transcriptionally activating HIF-2α. This evidence concerns the gene SIPA1 and breast cancer.